Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review
Conclusions
Based on the findings from this review of real-world comparative effectiveness studies, risks of FN and FN-related complications were generally lower for prophylaxis with pegfilgrastim versus prophylaxis with short-acting G-CSFs.
Source: Journal of Oncology Pharmacy Practice - Category: Cancer & Oncology Authors: Mitchell, S., Li, X., Woods, M., Garcia, J., Hebard-Massey, K., Barron, R., Samuel, M. Tags: Review Articles Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Databases & Libraries | Filgrastim | Health | Health Management | Neulasta | Neupogen | Nurses | Nursing | Politics | Statistics | Study